527 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
451 | 11159798 | A flow cell assay for evaluation of whole cell drug efflux kinetics: analysis of paclitaxel efflux in CCRF-CEM leukemia cells overexpressing P-glycoprotein. | 2001 Feb | 1 |
452 | 11288109 | P-glycoprotein efflux pump expression and activity in Calu-3 cells. | 2001 May | 2 |
453 | 11329060 | The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. | 2001 May | 2 |
454 | 11392446 | Determinants of paclitaxel uptake, accumulation and retention in solid tumors. | 2001 May | 1 |
455 | 11410497 | The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6alpha-hydroxypaclitaxel, a major metabolite of paclitaxel. | 2001 Jun | 1 |
456 | 11465412 | P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrier. | 2001 May | 2 |
457 | 11496948 | Mdr1 transfection causes enhanced apoptosis by paclitaxel: an effect independent of drug efflux function of P-glycoprotein. | 2001 Jul | 5 |
458 | 11504769 | Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance. | 2001 Aug 15 | 6 |
459 | 11504826 | Kinetics of P-glycoprotein-mediated efflux of paclitaxel. | 2001 Sep | 7 |
460 | 11552225 | Pharmacokinetic profiles of doxorubicin in combination with taxanes. | 2001 Aug | 2 |
461 | 11564553 | The relationship between Taxol and (+)-discodermolide: synthetic analogs and modeling studies. | 2001 Sep | 1 |
462 | 11605182 | Predicting response to paclitaxel/carboplatin-based therapy in non-small cell lung cancer. | 2001 Aug | 1 |
463 | 11606389 | The farnesyl protein transferase inhibitor SCH66336 is a potent inhibitor of MDR1 product P-glycoprotein. | 2001 Oct 15 | 2 |
464 | 11606393 | Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma. | 2001 Oct 15 | 2 |
465 | 11668581 | Abundant expression of the microtubule-associated protein, ensconsin (E-MAP-115), alters the cellular response to Taxol. | 2001 Jul | 1 |
466 | 11710832 | Cross-talk between signalling pathways and the multidrug resistant protein MDR-1. | 2001 Oct 19 | 2 |
467 | 11780384 | Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides. | 2001 Sep | 4 |
468 | 11891611 | Technetium-99m tetrofosmin chest imaging related to p-glycoprotein expression for predicting the response with paclitaxel-based chemotherapy for non-small cell lung cancer. | 2001 | 2 |
469 | 11925927 | Analyses by comparative genomic hybridization of genes relating with cisplatin-resistance in ovarian cancer. | 2001 Dec | 2 |
470 | 10601617 | Clofazimine and B4121 sensitize an intrinsically resistant human colon cancer cell line to P-glycoprotein substrates. | 2000 Jan-Feb | 3 |
471 | 10741911 | Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines. | 2000 Mar | 1 |
472 | 10745175 | Strength and specificity of different gene promoters in oral cancer cells. | 2000 Mar | 1 |
473 | 10755318 | N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs. | 2000 | 1 |
474 | 10803921 | Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxel. | 2000 | 1 |
475 | 10872505 | Detection of recombinant P-glycoprotein in multidrug resistant cultured cells. | 2000 Feb | 2 |
476 | 10912951 | Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP-mediated camptothecin derivative-resistant variants derived from the human lung cancer cell line PC-6. | 2000 Jun | 2 |
477 | 10918072 | MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping. | 2000 Aug 4 | 2 |
478 | 11036469 | Multidrug resistance phenotype and paclitaxel (Taxol) sensitivity in human renal carcinoma cell lines of different histologic types. | 2000 | 5 |
479 | 11052631 | Multiple factors other than p53 influence colon cancer sensitivity to paclitaxel. | 2000 | 1 |
480 | 11104578 | Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors. | 2000 Dec | 1 |
481 | 11106232 | Phase I trial of paclitaxel plus megestrol acetate in patients with paclitaxel-refractory ovarian cancer. | 2000 Nov | 2 |
482 | 11205313 | PSC 833 induces apoptosis in drug-sensitive human leukemia cell line and modulates resistance to paclitaxel in its multidrug-resistant variant. | 2000 Nov-Dec | 5 |
483 | 11218898 | [Study of mdr1 antisense oligodeoxynucleotides on reversal of multidrug resistance in ovarian carcinoma cell line SKOV3]. | 2000 Nov | 1 |
484 | 11809106 | [The expression of multiple drug resistance associated genes in ovarian cancer]. | 2000 Feb | 1 |
485 | 11876985 | [Exploration of factors increasing transfer efficiency of retroviral mediated multidrug resistance gene (mdr1) into human CD(34)(+) cells]. | 2000 May | 2 |
486 | 9864431 | The chemosensitizing potential of GF120918 is independent of the magnitude of P-glycoprotein-mediated resistance to conventional chemotherapeutic agents in a small cell lung cancer line. | 1999 Jan-Feb | 3 |
487 | 10100591 | The bisindolylmaleimide protein kinase C inhibitor, Ro 32-2241, reverses multidrug resistance in KB tumour cells. | 1999 | 1 |
488 | 10193934 | Effects of paclitaxel on the growth of normal, polyposis, and cancerous human colonic epithelial cells. | 1999 Apr 1 | 2 |
489 | 10430060 | Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients. | 1999 Jul | 5 |
490 | 10453729 | A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxel. | 1999 | 1 |
491 | 10576649 | The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells. | 1999 Nov | 3 |
492 | 10602425 | Drug-resistance enables selective killing of resistant leukemia cells: exploiting of drug resistance instead of reversal. | 1999 Dec | 1 |
493 | 11498350 | Molecular mechanisms of resistance to taxanes and therapeutic implications. | 1999 Dec | 1 |
494 | 11550305 | Characterization of paclitaxel (Taxol) sensitivity in human glioma- and medulloblastoma-derived cell lines. | 1999 Apr | 1 |
495 | 9510502 | Reversal of multidrug resistance by novel verapamil analogs in cancer cells. | 1998 Feb | 2 |
496 | 9516927 | Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin. | 1998 Feb | 6 |
497 | 9531522 | Taxol transport by human intestinal epithelial Caco-2 cells. | 1998 Apr | 1 |
498 | 9572489 | Overexpression of both p185c-erbB2 and p170mdr-1 renders breast cancer cells highly resistant to taxol. | 1998 Apr 23 | 3 |
499 | 9625436 | The bisbenzylisoquinoline alkaloids, tetrandine and fangchinoline, enhance the cytotoxicity of multidrug resistance-related drugs via modulation of P-glycoprotein. | 1998 Mar | 1 |
500 | 9738565 | Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP. | 1998 Sep | 1 |